Published in J Clin Pathol on November 01, 1999
EPMA position paper in cancer: current overview and future perspectives. EPMA J (2015) 1.04
Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance. J Clin Pathol (2000) 1.02
Prognostic factors in prostate cancer. BMJ (2001) 0.78
The potential for prostate cancer chemoprevention. Rev Urol (2002) 0.77
Tissue-based assay for ornithine decarboxylase to identify patients likely to respond to difluoromethylornithine. J Histochem Cytochem (2004) 0.75
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06
A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst (1993) 3.40
Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst (1998) 2.97
Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst (1997) 2.74
Telomeres, telomerase, and immortality. J Natl Cancer Inst (1995) 2.12
Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A (1993) 2.09
Plasma concentrations of phyto-oestrogens in Japanese men. Lancet (1993) 2.01
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res (1993) 1.96
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res (1994) 1.85
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res (1995) 1.85
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes Cancer (1991) 1.61
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev (1998) 1.59
Prediagnostic serum selenium and risk of cancer. Lancet (1983) 1.54
Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res (1995) 1.52
Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res (1994) 1.52
Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol (1996) 1.46
Regulation of selenoproteins. Annu Rev Nutr (1993) 1.37
Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol (1995) 1.33
Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst (1990) 1.33
Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst (1988) 1.30
Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res (1996) 1.28
Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res (1994) 1.24
Topography of neovascularity in human prostate carcinoma. Cancer (1995) 1.18
Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res (1994) 1.16
Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer (1994) 1.15
Nuclear morphometry in solar keratosis. Anal Quant Cytol Histol (1998) 1.12
Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology (1997) 1.02
Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol (1988) 1.01
Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. Cancer Res (1993) 1.01
Androgen signal transduction and prostatic carcinoma. World J Urol (1994) 1.00
Chromatin texture signatures in nuclei from prostate lesions. Anal Quant Cytol Histol (1998) 0.99
Precursors of prostatic cancer: progression, regression and chemoprevention. Eur Urol (1996) 0.98
Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol (1993) 0.95
Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosomes Cancer (1995) 0.94
Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial. Prostate (1997) 0.94
Histopathological effects of androgen deprivation in prostatic cancer. Semin Urol Oncol (1996) 0.92
Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone. Carcinogenesis (1995) 0.91
Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urology (1994) 0.90
The preventive role of diet in prostatic disease. Br J Urol (1996) 0.90
Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle. Cancer Res (1993) 0.89
Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine. J Natl Cancer Inst (1993) 0.89
Analysis of the capillary architecture in the precursors of prostate cancer: recent findings and new concepts. Eur Urol (1996) 0.88
The role of prostate-specific antigen in the chemoprevention of prostate cancer. J Cell Biochem Suppl (1996) 0.87
Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer? Br J Urol (1997) 0.87
Quantitative characterization of the frequency and location of cell proliferation and death in prostate pathology. J Cell Biochem Suppl (1994) 0.86
Human prostate cancer cells: inhibition of proliferation by vitamin D analogs. Anticancer Res (1994) 0.86
Antagonism of androgen action in prostate tumor cells by retinoic acid. Prostate (1994) 0.85
Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion. Clin Cancer Res (1997) 0.85
Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. Am J Clin Pathol (1991) 0.84
Vitamin A regulates proliferation and differentiation of human prostatic epithelial cells. Prostate (1993) 0.84
Quantitative study of ductal breast cancer progression. A progression index (P.I.) for premalignant lesions and in situ carcinoma. Pathol Res Pract (1996) 0.84
Vitamin D and prostate cancer. Adv Exp Med Biol (1995) 0.83
Biomarker end-points in cancer chemoprevention trials. IARC Sci Publ (1997) 0.83
Development of new cancer chemoprevention agents: role of pharmacokinetic/pharmacodynamic and intermediate endpoint biomarker monitoring. Clin Chem (1998) 0.80
Effectiveness of complete versus partial androgen withdrawal therapy for the treatment of prostatic cancer as studied in the Dunning R-3327 system of rat prostatic adenocarcinomas. Cancer Res (1985) 0.80
Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents. Cancer Res (1996) 0.80
Potential use of image analysis for the evaluation of cellular predicting factors for therapeutic response in breast cancers. Anal Quant Cytol Histol (1997) 0.80
Chemoprevention in prostate cancer: the role of difluoromethylornithine (DFMO). J Cell Biochem Suppl (1992) 0.79
Statistical histometry of the basal cell/secretory cell bilayer in prostatic intraepithelial neoplasia. Anal Quant Cytol Histol (1998) 0.79
Strategies for identification and clinical evaluation of promising chemopreventive agents. Oncology (Williston Park) (1996) 0.78
Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia. J Cell Biochem Suppl (1994) 0.78
Chemoprevention strategies for prostate cancer: the role of 5 alpha-reductase inhibitors. J Cell Biochem Suppl (1992) 0.78
Target populations and strategies for chemoprevention trials of prostate cancer. J Cell Biochem Suppl (1994) 0.77
Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading. Cancer Res (1994) 0.77
Prostatic intraepithelial neoplasia. Quantitation of the basal cell layer with machine vision system. Pathol Res Pract (1995) 0.76
Induction of invasive carcinomas of the seminal vesicles and coagulating glands of F344 rats by administration of N-methylnitrosourea or N-nitrosobis(2-oxopropyl)amine and followed by testosterone propionate with or without high-fat diet. Carcinogenesis (1991) 0.76
Quantitative analysis of prostatic intraepithelial neoplasia on tissue sections. Anal Quant Cytol Histol (1990) 0.76
Machine vision in the detection of prostate lesions in histologic sections. Anal Quant Cytol Histol (1998) 0.76
The Lobund-Wistar rat model of prostate cancer. J Cell Biochem Suppl (1992) 0.76
Prostate cancer prevention: investigational approaches and opportunities. Cancer Res (1996) 0.76
Potential markers of aggressiveness in prostatic intraepithelial neoplasia detected by fluorescence in situ hybridization. Eur Urol (1996) 0.76
Chemoprevention for prostatic intraepithelial neoplasia. Eur Urol (1996) 0.76
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65
Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med (2000) 4.08
Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA (1996) 3.18
Patient attitudes following participation in a health outcome survey. Am J Public Health (1981) 2.96
Invited commentary: Factor analysis and the search for objectivity. Am J Epidemiol (1998) 2.95
Colon cancer reduction. Questions about implementation of proven techniques. Arch Intern Med (1997) 2.12
Beta-carotene: a miss for epidemiology. J Natl Cancer Inst (1999) 2.07
Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology (2001) 1.88
Risk of premenopausal breast cancer and use of electric blankets. Am J Epidemiol (1994) 1.85
Pituitary and gonadal hormones in women during spontaneous and induced ovulatory cycles. Recent Prog Horm Res (1970) 1.82
Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res (1998) 1.80
Measuring life stress: factors affecting fall-off in the reporting of life events. J Health Soc Behav (1984) 1.80
Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol (1972) 1.76
On the distortion of risk estimates in multiple exposure level case-control studies. Am J Epidemiol (1981) 1.73
While a phobic waits: regional brain electrical and autonomic activity in social phobics during anticipation of public speaking. Biol Psychiatry (2000) 1.72
Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev (1999) 1.72
Measurement of current exposure to environmental tobacco smoke. Arch Environ Health (1990) 1.66
Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res (1999) 1.57
Infant mortality: a multi-level analysis of individual and community risk factors. Soc Sci Med (1998) 1.56
Lactation history and breast cancer risk. Am J Epidemiol (1997) 1.54
Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res (1995) 1.54
Cellular phones and traffic accidents: an epidemiological approach. Accid Anal Prev (1996) 1.53
Exposure to breastmilk in infancy and the risk of breast cancer. Epidemiology (1994) 1.53
Pituitary tumors and pregnancy. Am J Obstet Gynecol (1978) 1.51
Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States) Cancer Causes Control (1997) 1.51
The problem of profound mismeasurement and the power of epidemiological studies of diet and cancer. Nutr Cancer (1988) 1.50
The bacteriology of acute pelvic inflammatory disease. Am J Obstet Gynecol (1975) 1.46
Diet in the epidemiology of endometrial cancer in western New York (United States). Cancer Causes Control (2000) 1.45
Reliability and validity of a self-administered food frequency questionnaire in a chemoprevention trial of adenoma recurrence. Cancer Epidemiol Biomarkers Prev (1999) 1.42
Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol (1991) 1.37
Test-retest reliability of the cognitive lifetime drinking history. Am J Epidemiol (1997) 1.32
Patterns in food use and their associations with nutrient intakes. Am J Clin Nutr (1990) 1.31
Corpus luteum function in early pregnancy. J Clin Endocrinol Metab (1969) 1.30
Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol (1995) 1.30
Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (1998) 1.30
How to develop and use a Bayesian Belief Network. J Clin Pathol (1996) 1.29
An automated machine vision system for the histological grading of cervical intraepithelial neoplasia (CIN). J Pathol (2000) 1.28
Analysis of patterns of food intake in nutritional epidemiology: food classification in principal components analysis and the subsequent impact on estimates for endometrial cancer. Public Health Nutr (2001) 1.27
Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am J Prev Med (1990) 1.26
Measurement of chemopreventive efficacy in skin biopsies. Anal Quant Cytol Histol (2001) 1.25
Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst (1996) 1.24
Cardiopulmonary complications during laparoscopy: two case reports. South Med J (1995) 1.23
Plasma gonadotropins during clomiphene induced ovulatory cycles. Am J Obstet Gynecol (1968) 1.22
Improved diagnostic decision-making in pathology: do inference networks hold the key? J Pathol (1995) 1.20
Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer (2005) 1.20
Diet and lung cancer risk: findings from the Western New York Diet Study. Am J Epidemiol (1987) 1.17
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals. Antivir Ther (2000) 1.16
Radiosensitivity of T and B lymphocytes. IV. Effect of whole body irradiation upon various lymphoid tissues and numbers of recirculating lymphocytes. J Immunol (1977) 1.15
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev (1996) 1.15
The ultrastructure of uncomplicated human atheroma in surgically resected aortas. J Atheroscler Res (1966) 1.15
Expert system support using Bayesian belief networks in the diagnosis of fine needle aspiration biopsy specimens of the breast. J Clin Pathol (1994) 1.14
Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (1999) 1.13
The lipophage in hyperlipemic rats: an electron microscopic study. Exp Mol Pathol (1966) 1.13
Nuclear morphometry in solar keratosis. Anal Quant Cytol Histol (1998) 1.12
Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res (1999) 1.12
DNA ploidy profiles as prognostic indicators in CIN lesions. Am J Clin Pathol (1989) 1.10
Automated location of dysplastic fields in colorectal histology using image texture analysis. J Pathol (1997) 1.10
Dietary fat consumption and survival among women with breast cancer. J Natl Cancer Inst (1985) 1.10
Measurement of lifetime exposure to passive smoke. Am J Epidemiol (1989) 1.08
Stress and suicide in the Nurses' Health Study. J Epidemiol Community Health (2002) 1.08
Anaerobic infections of the female genital tract: prospects and perspectives. Obstet Gynecol Surv (1975) 1.08
Evaluation of ovulation and corpus luteum function using measurements of plasma progesterone. Obstet Gynecol (1974) 1.08
The expression of feelings. Arch Gen Psychiatry (1972) 1.08
Social environment and breast cancer. A cohort analysis of patient survival. Cancer (1983) 1.07
Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.06
Gender differences in the relation between depressive symptoms and alcohol problems: a longitudinal perspective. Am J Epidemiol (1997) 1.06
Self-efficacy and confidence in outcomes as determinants of self-care practices in inner-city, African-American women with non-insulin-dependent diabetes. Diabetes Educ (1995) 1.06
Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol Appl Pharmacol (1979) 1.06
Cell recognition from line scan transition probability profiles. Acta Cytol (1969) 1.06
Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst (1999) 1.05
Significance probability mapping: an aid in the topographic analysis of brain electrical activity. Electroencephalogr Clin Neurophysiol (1981) 1.03
Prostatic intraepithelial neoplasia. Development of a Bayesian belief network for diagnosis and grading. Anal Quant Cytol Histol (1994) 1.02
Dietary history from the distant past: a methodological study. Nutr Cancer (1983) 1.02
Serum progesterone and estradiol-17beta levels in premature and term labor. Am J Obstet Gynecol (1977) 1.02
Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance. J Clin Pathol (2000) 1.02
Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study. Anticancer Drugs (2003) 1.01
Occupational exposure to extreme temperature and risk of testicular cancer. Arch Environ Health (1995) 1.01
Dietary patterns and colon cancer in western New York. Nutr Cancer (1992) 1.01
Comparison of three methods of teaching women how to perform breast self-examination. Health Educ Q (1985) 1.01
Prostatic intraepithelial neoplasia (PIN). Performance of Bayesian belief network for diagnosis and grading. J Pathol (1995) 1.00
Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology (2001) 1.00
The gravity suit: a major advance in management of gynecologic blood loss. Obstet Gynecol (1979) 1.00
Kidney donors--the myth of informed consent. Am J Psychiatry (1970) 0.99
Use of an information retrieval service in an obstetrics/gynecology residency program. J Med Educ (1980) 0.99
Alcohol consumption and lung cancer in white males. Cancer Causes Control (1992) 0.99
Computerized scene segmentation for the discrimination of architectural features in ductal proliferative lesions of the breast. J Pathol (1997) 0.99
Image analysis in quantitative cytopathology and histopathology. Hum Pathol (1989) 0.98
Diet and smoking in the epidemiology of cancer of the cervix. J Natl Cancer Inst (1983) 0.98
Body mass index, weight gain, and risk of endometrial cancer. Nutr Cancer (1995) 0.97
The doctor, the dying patient, and the bereaved. Ann Intern Med (1969) 0.96
Biologic and morphologic development of donated human ova recovered by nonsurgical uterine lavage. Am J Obstet Gynecol (1985) 0.96
PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells. Oncogene (2011) 0.95
Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer. J Clin Pathol (2002) 0.95
Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens. J Urol (2005) 0.94
A hybrid neural and statistical classifier system for histopathologic grading of prostatic lesions. Anal Quant Cytol Histol (1995) 0.94
Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med (1991) 0.94
Taxonomic intra-cellular analytic system (TIICAS) for cell identification. Acta Cytol (1968) 0.94